PMID: 9654592Jul 9, 1998Paper

Chemotherapy of oesophago-gastric cancer

Pathology Oncology Research : POR
P J RossD Cunningham

Abstract

Oesophageal and gastric cancers are common tumors that represent a number of challenges for oncologists, gastroenterologists and surgeons. The prognosis remains poor with the majority of patients presenting with advanced disease. Combined chemotherapy and radiotherapy has demonstrated a survival benefit in patients with loco-regional oesophageal cancer compared to radiotherapy alone. In an interim analysis we have observed a 62% response rate using a chemoradiation regimen based on protracted venous infusion of 5-fluorouracil and cisplatin combined with radiotherapy in patients with inoperable oesophageal cancer. Improved outcomes with loco-regional disease has rekindled interest in preoperative therapy. In a trial comparing preoperative chemoradiation to surgery alone in patients with operable oesophageal adenocarcinoma, survival was improved with multimodality treatment. In addition, a study including both adeno- and squamous carcinomas demonstrated a trend towards improved survival. A complete pathological response to chemoradiation was associated with significantly improved survival. Gastric cancer is one of the most chemosensitive solid tumors of the gastrointestinal tract with the majority of patients being suitable for p...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KelsenM Brennan
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A ForastiereM Zahurak
Jun 1, 1989·The British Journal of Surgery·W H AllumJ W Fielding
Aug 1, 1988·American Journal of Clinical Oncology·T MoynihanM Vukelich
May 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D MachoverJ B Fourtillan
Apr 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E PoplinS E Rivkin
Jul 1, 1980·The British Journal of Surgery·R Earlam, J R Cunha-Melo
Dec 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H O DouglassA R Paul
Mar 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusP O Sjödén
Sep 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M FindlayH Ford
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A CullinanL K Tschetter
Aug 15, 1996·The New England Journal of Medicine·T N WalshT P Hennessy
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M al-SarrafB Emami
Feb 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusR Heuman

❮ Previous
Next ❯

Citations

Jun 7, 2002·Gut·W H AllumUNKNOWN British Association of Surgical Oncology
Mar 15, 2001·Clinical Radiology·M GolderA C Steger
Dec 18, 2001·Medical and Pediatric Oncology·H ZotterT Hinterleitner
Sep 22, 2010·Ophthalmic Plastic and Reconstructive Surgery·Omega PriyadarshiniSuryasnata Rath
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David R FerryJanusz Jankowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.